Major journals and societies push new studies across oncology, neurology, radiology, infectious disease, and critical care, emphasizing newly accepted papers, trial results, and imaging analyses.
Early results of an investigational HER3-targeting antibody-drug conjugate (ADC) showed anti-tumor activity
Now online: HER2 heterogeneous breast cancer models reveal novel therapeutic targets
New #BMJResearch
✅ Just Accepted
New in #CriticalCare
This finding is one of many signals tracked across Healthcare. The live feed updates every few hours with new authority voices, debates, and emerging ideas.
← Back to Healthcare